
Indoco Remedies Limited has informed the Exchange regarding a press release dated March 09, 2021, titled "INDOCO ANNOUNCES THE LAUNCH OF BRINZOLAMIDE OPHTHALMIC SUSPENSION 1% IN THE US MARKET BY TEVA PHARMACEUTICALS".
Filed with NSE ·

Indoco Remedies Limited has informed the Exchange regarding a press release dated March 09, 2021, titled "INDOCO ANNOUNCES THE LAUNCH OF BRINZOLAMIDE OPHTHALMIC SUSPENSION 1% IN THE US MARKET BY TEVA PHARMACEUTICALS".
6ix hasn’t read this filing yet.
Indoco Remedies Limited on 6ix
Follow Indoco Remedies into a list and get an email when it puts out news.
Follow Indoco Remedies